Arbutus Biopharma(ABUS) - 2023 Q3 - Earnings Call Transcript

Arbutus Biopharma Corporation. (NASDAQ:ABUS) Q3 2023 Earnings Conference Call November 7, 2023 9:00 AM ET Company Participants Lisa Caperelli - VP of IR Bill Collier - President, CEO and Director David Hastings - CFO and CAO Karen Sims - Chief Medical Officer Michael Sofia - Chief Scientific Officer Michael McElhaugh - Chief Operating Officer Conference Call Participants Roy Buchanan - JMP Operator Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate and Financial Update C ...